Matches in Wikidata for { <http://www.wikidata.org/entity/Q80421968> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q80421968 description "article scientifique publié en 2007" @default.
- Q80421968 description "artículu científicu espublizáu en xunu de 2007" @default.
- Q80421968 description "scientific article published on 01 June 2007" @default.
- Q80421968 description "wetenschappelijk artikel" @default.
- Q80421968 description "наукова стаття, опублікована в червні 2007" @default.
- Q80421968 name "A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients" @default.
- Q80421968 name "A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients" @default.
- Q80421968 type Item @default.
- Q80421968 label "A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients" @default.
- Q80421968 label "A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients" @default.
- Q80421968 prefLabel "A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients" @default.
- Q80421968 prefLabel "A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients" @default.
- Q80421968 P1433 Q80421968-CA173271-3841-4A59-A8DC-3B2029D571D5 @default.
- Q80421968 P1476 Q80421968-E7A8588B-D10D-4387-B26C-DF50544D689A @default.
- Q80421968 P2093 Q80421968-05511D06-EBC6-4E6C-B6C2-52926CA987F9 @default.
- Q80421968 P2093 Q80421968-2EA2650A-0306-407D-855C-C95E57ABA6F8 @default.
- Q80421968 P2093 Q80421968-49CE7E7E-9CFA-4CD2-983E-4662AF23815A @default.
- Q80421968 P2093 Q80421968-5C291DE2-83D3-4C90-B1BA-7A8276BE96FC @default.
- Q80421968 P2093 Q80421968-6461C353-428A-489C-99A6-DC7787214DA6 @default.
- Q80421968 P2093 Q80421968-A4ACB5A9-9205-4C2B-AA71-0EB397099DF4 @default.
- Q80421968 P2093 Q80421968-E4C0319C-D7CB-4888-A736-52460078187D @default.
- Q80421968 P304 Q80421968-0F894C30-C53E-4ED0-82F7-EC981166311D @default.
- Q80421968 P31 Q80421968-A703756B-56E9-4C69-A924-31D6F237EEA3 @default.
- Q80421968 P356 Q80421968-9027BB60-8566-496F-84DF-37EFDBF352C1 @default.
- Q80421968 P433 Q80421968-BF6753CA-F613-4C73-93A8-0EFB764BA35D @default.
- Q80421968 P478 Q80421968-C834B507-0E26-4912-A1F0-811D50E3C1AB @default.
- Q80421968 P50 Q80421968-9D1C7EA1-7A2A-4540-B065-8842564CBD6E @default.
- Q80421968 P50 Q80421968-E1F4EFCC-CD4D-4FE4-83E7-15266A6D3D83 @default.
- Q80421968 P577 Q80421968-63C86CD2-7B85-4781-8C70-9A6068587BB6 @default.
- Q80421968 P698 Q80421968-15BECE09-A681-4F74-8D55-4DB146FF7CF4 @default.
- Q80421968 P356 1078-0432.CCR-06-2414 @default.
- Q80421968 P698 17545533 @default.
- Q80421968 P1433 Q332253 @default.
- Q80421968 P1476 "A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients" @default.
- Q80421968 P2093 "Elaine M Paul" @default.
- Q80421968 P2093 "Els O Witteveen" @default.
- Q80421968 P2093 "Emile E Voest" @default.
- Q80421968 P2093 "Isa E L M Kuppens" @default.
- Q80421968 P2093 "Roxanne C Jewell" @default.
- Q80421968 P2093 "Sandra A Radema" @default.
- Q80421968 P2093 "Steve G Mangum" @default.
- Q80421968 P304 "3276-3285" @default.
- Q80421968 P31 Q13442814 @default.
- Q80421968 P356 "10.1158/1078-0432.CCR-06-2414" @default.
- Q80421968 P433 "11" @default.
- Q80421968 P478 "13" @default.
- Q80421968 P50 Q23771643 @default.
- Q80421968 P50 Q89824209 @default.
- Q80421968 P577 "2007-06-01T00:00:00Z" @default.
- Q80421968 P698 "17545533" @default.